Reimbursement and Coding Guide for REVLIMID
The information below is designed to help appropriate patients get access to REVLIMID by providing helpful reimbursement information for healthcare offices. It is important that offices verify each patient’s insurance coverage prior to initiating therapy. BMS Access Support may be able to help.
Relapsed Mantle Cell Lymphoma
Previously Treated Follicular Lymphoma
Previously Treated Marginal Zone Lymphoma
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.